Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SENAVA: Seminal Plasma in IVF
NCT02716753Completed
- Sponsor
- Region Östergötland
- Start
- Nov 2016
- Primary completion
- Mar 2023
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of seminal plasma in infertility (2 arms), sponsored by Region Östergötland. Primary endpoints: Pregnancy rate at 40 weeks and Live birth rate at 40 weeks. Started Nov 2016; status: completed.
02
Drugs
seminal plasma
03
Conditions
infertility
Beyond the preview
Go deeper on NCT02716753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02716753.